Charles River Laboratories International (CRL) Long-Term Deferred Tax (2010 - 2025)

Charles River Laboratories International's Long-Term Deferred Tax history runs 16 years deep, the most recent figure standing at $67.3 million for Q4 2025.

• In Q4 2025, Long-Term Deferred Tax rose 59.64% year-over-year to $67.3 million; the TTM figure through Dec 2025 stood at $67.3 million (up 59.64% YoY), while the FY2025 annual figure was $67.3 million, up 59.64% from the prior year.
• Long-Term Deferred Tax was $67.3 million for Q4 2025 at Charles River Laboratories International, up from $36.9 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $67.3 million in Q4 2025 to a low of $31.9 million in Q2 2021.
• Historically, Long-Term Deferred Tax has averaged $41.1 million across 5 years, with a median of $40.3 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Long-Term Deferred Tax decreased 25.48% in 2021, then jumped 59.64% in 2025.
• A 5-year view of Long-Term Deferred Tax shows it stood at $40.2 million in 2021, then increased by 2.58% to $41.3 million in 2022, then decreased by 2.38% to $40.3 million in 2023, then advanced by 4.72% to $42.2 million in 2024, then surged by 59.64% to $67.3 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $67.3 million (Q4 2025), $36.9 million (Q3 2025), and $46.9 million (Q2 2025), per Business Quant data.